Anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic activities of Plinia cauliflora (Mart.) Kausel (Brazilian grape) epicarp
Plinia cauliflora (Mart.) Kausel, known in Brazil as jabuticaba or jaboticaba has been used by Brazilian native populations for medicinal purposes, including those related to inflammatory conditions, such as asthma, diarrhea, disorders in female genitourinary tract, and tonsillitis. Inflammation has...
Gespeichert in:
Veröffentlicht in: | Journal of ethnopharmacology 2021-03, Vol.268 (NA), p.113611, Article 113611 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | NA |
container_start_page | 113611 |
container_title | Journal of ethnopharmacology |
container_volume | 268 |
creator | Brito, Thaíse Gabriele da Silva Silva, Ana Paula Sant’Anna da Cunha, Rebeca Xavier da Fonseca, Caíque Silveira Martins da Araújo, Tiago Ferreira da Silva Campos, Janaína Karin de Lima Nascimento, Weber Melo Araújo, Hallysson Douglas Andrade de Silva, Joanda Paolla Raimundo e Tavares, Josean Fechine Santos, Bianka Santana dos Lima, Vera Lúcia de Menezes |
description | Plinia cauliflora (Mart.) Kausel, known in Brazil as jabuticaba or jaboticaba has been used by Brazilian native populations for medicinal purposes, including those related to inflammatory conditions, such as asthma, diarrhea, disorders in female genitourinary tract, and tonsillitis. Inflammation has emerged as a main factor for the oxidative stress, hyperglycemia, and dyslipidemia present in chronic noncommunicable diseases (NCDs). Such disturbances have been a leading cause of death worldwide for decades, despite significant efforts in developing new therapies. Therefore, strengthening the relevance of ethnobotanic approaches, as P. cauliflora has the potential to become a natural, native, and traditional product to prevent and treat inflammation-associated diseases more effectively for more people.
Evaluate anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic properties of hydroethanolic extract of P. cauliflora epicarps (PcE).
Phytochemical compound from the PcE were identified through HPLC-DAD-ESI-MSn analysis. Antioxidant activity was determined by measuring 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging. The anti-inflammatory potential was investigated by carrageenan-induced paw edema and peritonitis in mice. Analgesic effect was assessed, in mice, though hot plate test and acetic acid-induced abdominal writhing. Antidiabetic and hypolipidemic potential were evaluated using alloxan-induced diabetic mice.
Tannins, phenolic acids, and their derivatives were the predominant phytochemicals found. Overall, PcE showed different properties related to the treatment of clinical conditions associated with chronic diseases as a potent antioxidant activity, demonstrating a radical scavenging action similar to gallic acid. PcE oral administration also significantly reduced inflammation induced by paw edema and partially blocked leukocyte migration. Moreover, PcE produced peripheral and central analgesic effects, as evaluated in the writhing model and hot plate tests. Treatment with PcE significantly improved glucose levels and lipid markers in diabetic mice.
P. cauliflora fruits are rich sources of secondary metabolites, mainly tannins and phenolic acids with high biological potential, which can effectively contribute to the approach of preventing and controlling chronic NCDs.
[Display omitted]
•Phenolic profile mainly composed by tannins, phenolic acids, and their derivatives.•Antioxidant activity similar to Gallic Acid, measured by DPPH.• |
doi_str_mv | 10.1016/j.jep.2020.113611 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2635175702</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378874120334991</els_id><sourcerecordid>2635175702</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-755d8fa531e05fca42364f90479b01168e7f498b01d434075e258dc2321016b13</originalsourceid><addsrcrecordid>eNp9kMtuFDEQRS1ERCaBD2CDvJxI6cGP7naPWIWIlxIEC1hbNe7yUCP3A7s70vABfDcedWDJolR1pVtXuoexl1JspJD168PmgONGCZW11LWUT9hKNkYVpjL6KVsJbZqiMaU8ZxcpHYQQRpbiGTvXWpWqVnrFft_0ExXU-wBdB9MQj9f8x3Ec9uHosCO3qEAjtYuEvs0DYY-JHAc30QNNhIkPnn8N1BNwB3MgH4YIfP0Z4rS54ncwJwx8_TbCLwoEPd9HGPGK40gO4vicnXkICV887kv2_f27b7cfi_svHz7d3twXTjf1lHtVbeOh0hJF5R2UStel34rSbHdCyrpB48ttk--21KUwFaqqaZ3S6sRrJ_UlWy-5Yxx-zpgm21FyGAL0OMzJqlpXMtMTKlvlYnVxSCmit2OkDuLRSmFPcfZgM357wm8X_Pnn1WP8vOuw_ffxl3c2vFkMmEs-EEabHGHvsKWIbrLtQP-J_wNUpJUH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2635175702</pqid></control><display><type>article</type><title>Anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic activities of Plinia cauliflora (Mart.) Kausel (Brazilian grape) epicarp</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Brito, Thaíse Gabriele da Silva ; Silva, Ana Paula Sant’Anna da ; Cunha, Rebeca Xavier da ; Fonseca, Caíque Silveira Martins da ; Araújo, Tiago Ferreira da Silva ; Campos, Janaína Karin de Lima ; Nascimento, Weber Melo ; Araújo, Hallysson Douglas Andrade de ; Silva, Joanda Paolla Raimundo e ; Tavares, Josean Fechine ; Santos, Bianka Santana dos ; Lima, Vera Lúcia de Menezes</creator><creatorcontrib>Brito, Thaíse Gabriele da Silva ; Silva, Ana Paula Sant’Anna da ; Cunha, Rebeca Xavier da ; Fonseca, Caíque Silveira Martins da ; Araújo, Tiago Ferreira da Silva ; Campos, Janaína Karin de Lima ; Nascimento, Weber Melo ; Araújo, Hallysson Douglas Andrade de ; Silva, Joanda Paolla Raimundo e ; Tavares, Josean Fechine ; Santos, Bianka Santana dos ; Lima, Vera Lúcia de Menezes</creatorcontrib><description>Plinia cauliflora (Mart.) Kausel, known in Brazil as jabuticaba or jaboticaba has been used by Brazilian native populations for medicinal purposes, including those related to inflammatory conditions, such as asthma, diarrhea, disorders in female genitourinary tract, and tonsillitis. Inflammation has emerged as a main factor for the oxidative stress, hyperglycemia, and dyslipidemia present in chronic noncommunicable diseases (NCDs). Such disturbances have been a leading cause of death worldwide for decades, despite significant efforts in developing new therapies. Therefore, strengthening the relevance of ethnobotanic approaches, as P. cauliflora has the potential to become a natural, native, and traditional product to prevent and treat inflammation-associated diseases more effectively for more people.
Evaluate anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic properties of hydroethanolic extract of P. cauliflora epicarps (PcE).
Phytochemical compound from the PcE were identified through HPLC-DAD-ESI-MSn analysis. Antioxidant activity was determined by measuring 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging. The anti-inflammatory potential was investigated by carrageenan-induced paw edema and peritonitis in mice. Analgesic effect was assessed, in mice, though hot plate test and acetic acid-induced abdominal writhing. Antidiabetic and hypolipidemic potential were evaluated using alloxan-induced diabetic mice.
Tannins, phenolic acids, and their derivatives were the predominant phytochemicals found. Overall, PcE showed different properties related to the treatment of clinical conditions associated with chronic diseases as a potent antioxidant activity, demonstrating a radical scavenging action similar to gallic acid. PcE oral administration also significantly reduced inflammation induced by paw edema and partially blocked leukocyte migration. Moreover, PcE produced peripheral and central analgesic effects, as evaluated in the writhing model and hot plate tests. Treatment with PcE significantly improved glucose levels and lipid markers in diabetic mice.
P. cauliflora fruits are rich sources of secondary metabolites, mainly tannins and phenolic acids with high biological potential, which can effectively contribute to the approach of preventing and controlling chronic NCDs.
[Display omitted]
•Phenolic profile mainly composed by tannins, phenolic acids, and their derivatives.•Antioxidant activity similar to Gallic Acid, measured by DPPH.•Reduced inflammation for 4 h, by paw edema and leukocyte migrations assays.•Reduced nociception evaluated by number of writhes (90%) and by hot plate test (2 h).•Glucose and lipid plasma levels better than those from diabetic or control animals.</description><identifier>ISSN: 0378-8741</identifier><identifier>EISSN: 1872-7573</identifier><identifier>DOI: 10.1016/j.jep.2020.113611</identifier><identifier>PMID: 33242623</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Alloxan ; Analgesics - isolation & purification ; Analgesics - therapeutic use ; Animals ; Anti-Inflammatory Agents - isolation & purification ; Anti-Inflammatory Agents - therapeutic use ; Brazil ; Diabetes Mellitus, Experimental - drug therapy ; Diabetes Mellitus, Experimental - metabolism ; Dose-Response Relationship, Drug ; Edema ; Edema - drug therapy ; Edema - metabolism ; Female ; Hypoglycemic Agents - isolation & purification ; Hypoglycemic Agents - therapeutic use ; Hypolipidemic Agents - isolation & purification ; Hypolipidemic Agents - therapeutic use ; Jaboticaba ; Mice ; Myrtaceae ; Plant Extracts - isolation & purification ; Plant Extracts - therapeutic use ; Random Allocation ; Scavenging ; Vitis ; Writhing</subject><ispartof>Journal of ethnopharmacology, 2021-03, Vol.268 (NA), p.113611, Article 113611</ispartof><rights>2020 Elsevier B.V.</rights><rights>Copyright © 2020 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-755d8fa531e05fca42364f90479b01168e7f498b01d434075e258dc2321016b13</citedby><cites>FETCH-LOGICAL-c386t-755d8fa531e05fca42364f90479b01168e7f498b01d434075e258dc2321016b13</cites><orcidid>0000-0002-0700-6849 ; 0000-0003-3313-039X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0378874120334991$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33242623$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brito, Thaíse Gabriele da Silva</creatorcontrib><creatorcontrib>Silva, Ana Paula Sant’Anna da</creatorcontrib><creatorcontrib>Cunha, Rebeca Xavier da</creatorcontrib><creatorcontrib>Fonseca, Caíque Silveira Martins da</creatorcontrib><creatorcontrib>Araújo, Tiago Ferreira da Silva</creatorcontrib><creatorcontrib>Campos, Janaína Karin de Lima</creatorcontrib><creatorcontrib>Nascimento, Weber Melo</creatorcontrib><creatorcontrib>Araújo, Hallysson Douglas Andrade de</creatorcontrib><creatorcontrib>Silva, Joanda Paolla Raimundo e</creatorcontrib><creatorcontrib>Tavares, Josean Fechine</creatorcontrib><creatorcontrib>Santos, Bianka Santana dos</creatorcontrib><creatorcontrib>Lima, Vera Lúcia de Menezes</creatorcontrib><title>Anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic activities of Plinia cauliflora (Mart.) Kausel (Brazilian grape) epicarp</title><title>Journal of ethnopharmacology</title><addtitle>J Ethnopharmacol</addtitle><description>Plinia cauliflora (Mart.) Kausel, known in Brazil as jabuticaba or jaboticaba has been used by Brazilian native populations for medicinal purposes, including those related to inflammatory conditions, such as asthma, diarrhea, disorders in female genitourinary tract, and tonsillitis. Inflammation has emerged as a main factor for the oxidative stress, hyperglycemia, and dyslipidemia present in chronic noncommunicable diseases (NCDs). Such disturbances have been a leading cause of death worldwide for decades, despite significant efforts in developing new therapies. Therefore, strengthening the relevance of ethnobotanic approaches, as P. cauliflora has the potential to become a natural, native, and traditional product to prevent and treat inflammation-associated diseases more effectively for more people.
Evaluate anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic properties of hydroethanolic extract of P. cauliflora epicarps (PcE).
Phytochemical compound from the PcE were identified through HPLC-DAD-ESI-MSn analysis. Antioxidant activity was determined by measuring 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging. The anti-inflammatory potential was investigated by carrageenan-induced paw edema and peritonitis in mice. Analgesic effect was assessed, in mice, though hot plate test and acetic acid-induced abdominal writhing. Antidiabetic and hypolipidemic potential were evaluated using alloxan-induced diabetic mice.
Tannins, phenolic acids, and their derivatives were the predominant phytochemicals found. Overall, PcE showed different properties related to the treatment of clinical conditions associated with chronic diseases as a potent antioxidant activity, demonstrating a radical scavenging action similar to gallic acid. PcE oral administration also significantly reduced inflammation induced by paw edema and partially blocked leukocyte migration. Moreover, PcE produced peripheral and central analgesic effects, as evaluated in the writhing model and hot plate tests. Treatment with PcE significantly improved glucose levels and lipid markers in diabetic mice.
P. cauliflora fruits are rich sources of secondary metabolites, mainly tannins and phenolic acids with high biological potential, which can effectively contribute to the approach of preventing and controlling chronic NCDs.
[Display omitted]
•Phenolic profile mainly composed by tannins, phenolic acids, and their derivatives.•Antioxidant activity similar to Gallic Acid, measured by DPPH.•Reduced inflammation for 4 h, by paw edema and leukocyte migrations assays.•Reduced nociception evaluated by number of writhes (90%) and by hot plate test (2 h).•Glucose and lipid plasma levels better than those from diabetic or control animals.</description><subject>Alloxan</subject><subject>Analgesics - isolation & purification</subject><subject>Analgesics - therapeutic use</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - isolation & purification</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Brazil</subject><subject>Diabetes Mellitus, Experimental - drug therapy</subject><subject>Diabetes Mellitus, Experimental - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Edema</subject><subject>Edema - drug therapy</subject><subject>Edema - metabolism</subject><subject>Female</subject><subject>Hypoglycemic Agents - isolation & purification</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Hypolipidemic Agents - isolation & purification</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>Jaboticaba</subject><subject>Mice</subject><subject>Myrtaceae</subject><subject>Plant Extracts - isolation & purification</subject><subject>Plant Extracts - therapeutic use</subject><subject>Random Allocation</subject><subject>Scavenging</subject><subject>Vitis</subject><subject>Writhing</subject><issn>0378-8741</issn><issn>1872-7573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtuFDEQRS1ERCaBD2CDvJxI6cGP7naPWIWIlxIEC1hbNe7yUCP3A7s70vABfDcedWDJolR1pVtXuoexl1JspJD168PmgONGCZW11LWUT9hKNkYVpjL6KVsJbZqiMaU8ZxcpHYQQRpbiGTvXWpWqVnrFft_0ExXU-wBdB9MQj9f8x3Ec9uHosCO3qEAjtYuEvs0DYY-JHAc30QNNhIkPnn8N1BNwB3MgH4YIfP0Z4rS54ncwJwx8_TbCLwoEPd9HGPGK40gO4vicnXkICV887kv2_f27b7cfi_svHz7d3twXTjf1lHtVbeOh0hJF5R2UStel34rSbHdCyrpB48ttk--21KUwFaqqaZ3S6sRrJ_UlWy-5Yxx-zpgm21FyGAL0OMzJqlpXMtMTKlvlYnVxSCmit2OkDuLRSmFPcfZgM357wm8X_Pnn1WP8vOuw_ffxl3c2vFkMmEs-EEabHGHvsKWIbrLtQP-J_wNUpJUH</recordid><startdate>20210325</startdate><enddate>20210325</enddate><creator>Brito, Thaíse Gabriele da Silva</creator><creator>Silva, Ana Paula Sant’Anna da</creator><creator>Cunha, Rebeca Xavier da</creator><creator>Fonseca, Caíque Silveira Martins da</creator><creator>Araújo, Tiago Ferreira da Silva</creator><creator>Campos, Janaína Karin de Lima</creator><creator>Nascimento, Weber Melo</creator><creator>Araújo, Hallysson Douglas Andrade de</creator><creator>Silva, Joanda Paolla Raimundo e</creator><creator>Tavares, Josean Fechine</creator><creator>Santos, Bianka Santana dos</creator><creator>Lima, Vera Lúcia de Menezes</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-0700-6849</orcidid><orcidid>https://orcid.org/0000-0003-3313-039X</orcidid></search><sort><creationdate>20210325</creationdate><title>Anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic activities of Plinia cauliflora (Mart.) Kausel (Brazilian grape) epicarp</title><author>Brito, Thaíse Gabriele da Silva ; Silva, Ana Paula Sant’Anna da ; Cunha, Rebeca Xavier da ; Fonseca, Caíque Silveira Martins da ; Araújo, Tiago Ferreira da Silva ; Campos, Janaína Karin de Lima ; Nascimento, Weber Melo ; Araújo, Hallysson Douglas Andrade de ; Silva, Joanda Paolla Raimundo e ; Tavares, Josean Fechine ; Santos, Bianka Santana dos ; Lima, Vera Lúcia de Menezes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-755d8fa531e05fca42364f90479b01168e7f498b01d434075e258dc2321016b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Alloxan</topic><topic>Analgesics - isolation & purification</topic><topic>Analgesics - therapeutic use</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - isolation & purification</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Brazil</topic><topic>Diabetes Mellitus, Experimental - drug therapy</topic><topic>Diabetes Mellitus, Experimental - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Edema</topic><topic>Edema - drug therapy</topic><topic>Edema - metabolism</topic><topic>Female</topic><topic>Hypoglycemic Agents - isolation & purification</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Hypolipidemic Agents - isolation & purification</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>Jaboticaba</topic><topic>Mice</topic><topic>Myrtaceae</topic><topic>Plant Extracts - isolation & purification</topic><topic>Plant Extracts - therapeutic use</topic><topic>Random Allocation</topic><topic>Scavenging</topic><topic>Vitis</topic><topic>Writhing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brito, Thaíse Gabriele da Silva</creatorcontrib><creatorcontrib>Silva, Ana Paula Sant’Anna da</creatorcontrib><creatorcontrib>Cunha, Rebeca Xavier da</creatorcontrib><creatorcontrib>Fonseca, Caíque Silveira Martins da</creatorcontrib><creatorcontrib>Araújo, Tiago Ferreira da Silva</creatorcontrib><creatorcontrib>Campos, Janaína Karin de Lima</creatorcontrib><creatorcontrib>Nascimento, Weber Melo</creatorcontrib><creatorcontrib>Araújo, Hallysson Douglas Andrade de</creatorcontrib><creatorcontrib>Silva, Joanda Paolla Raimundo e</creatorcontrib><creatorcontrib>Tavares, Josean Fechine</creatorcontrib><creatorcontrib>Santos, Bianka Santana dos</creatorcontrib><creatorcontrib>Lima, Vera Lúcia de Menezes</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of ethnopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brito, Thaíse Gabriele da Silva</au><au>Silva, Ana Paula Sant’Anna da</au><au>Cunha, Rebeca Xavier da</au><au>Fonseca, Caíque Silveira Martins da</au><au>Araújo, Tiago Ferreira da Silva</au><au>Campos, Janaína Karin de Lima</au><au>Nascimento, Weber Melo</au><au>Araújo, Hallysson Douglas Andrade de</au><au>Silva, Joanda Paolla Raimundo e</au><au>Tavares, Josean Fechine</au><au>Santos, Bianka Santana dos</au><au>Lima, Vera Lúcia de Menezes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic activities of Plinia cauliflora (Mart.) Kausel (Brazilian grape) epicarp</atitle><jtitle>Journal of ethnopharmacology</jtitle><addtitle>J Ethnopharmacol</addtitle><date>2021-03-25</date><risdate>2021</risdate><volume>268</volume><issue>NA</issue><spage>113611</spage><pages>113611-</pages><artnum>113611</artnum><issn>0378-8741</issn><eissn>1872-7573</eissn><abstract>Plinia cauliflora (Mart.) Kausel, known in Brazil as jabuticaba or jaboticaba has been used by Brazilian native populations for medicinal purposes, including those related to inflammatory conditions, such as asthma, diarrhea, disorders in female genitourinary tract, and tonsillitis. Inflammation has emerged as a main factor for the oxidative stress, hyperglycemia, and dyslipidemia present in chronic noncommunicable diseases (NCDs). Such disturbances have been a leading cause of death worldwide for decades, despite significant efforts in developing new therapies. Therefore, strengthening the relevance of ethnobotanic approaches, as P. cauliflora has the potential to become a natural, native, and traditional product to prevent and treat inflammation-associated diseases more effectively for more people.
Evaluate anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic properties of hydroethanolic extract of P. cauliflora epicarps (PcE).
Phytochemical compound from the PcE were identified through HPLC-DAD-ESI-MSn analysis. Antioxidant activity was determined by measuring 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging. The anti-inflammatory potential was investigated by carrageenan-induced paw edema and peritonitis in mice. Analgesic effect was assessed, in mice, though hot plate test and acetic acid-induced abdominal writhing. Antidiabetic and hypolipidemic potential were evaluated using alloxan-induced diabetic mice.
Tannins, phenolic acids, and their derivatives were the predominant phytochemicals found. Overall, PcE showed different properties related to the treatment of clinical conditions associated with chronic diseases as a potent antioxidant activity, demonstrating a radical scavenging action similar to gallic acid. PcE oral administration also significantly reduced inflammation induced by paw edema and partially blocked leukocyte migration. Moreover, PcE produced peripheral and central analgesic effects, as evaluated in the writhing model and hot plate tests. Treatment with PcE significantly improved glucose levels and lipid markers in diabetic mice.
P. cauliflora fruits are rich sources of secondary metabolites, mainly tannins and phenolic acids with high biological potential, which can effectively contribute to the approach of preventing and controlling chronic NCDs.
[Display omitted]
•Phenolic profile mainly composed by tannins, phenolic acids, and their derivatives.•Antioxidant activity similar to Gallic Acid, measured by DPPH.•Reduced inflammation for 4 h, by paw edema and leukocyte migrations assays.•Reduced nociception evaluated by number of writhes (90%) and by hot plate test (2 h).•Glucose and lipid plasma levels better than those from diabetic or control animals.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>33242623</pmid><doi>10.1016/j.jep.2020.113611</doi><orcidid>https://orcid.org/0000-0002-0700-6849</orcidid><orcidid>https://orcid.org/0000-0003-3313-039X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-8741 |
ispartof | Journal of ethnopharmacology, 2021-03, Vol.268 (NA), p.113611, Article 113611 |
issn | 0378-8741 1872-7573 |
language | eng |
recordid | cdi_proquest_miscellaneous_2635175702 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Alloxan Analgesics - isolation & purification Analgesics - therapeutic use Animals Anti-Inflammatory Agents - isolation & purification Anti-Inflammatory Agents - therapeutic use Brazil Diabetes Mellitus, Experimental - drug therapy Diabetes Mellitus, Experimental - metabolism Dose-Response Relationship, Drug Edema Edema - drug therapy Edema - metabolism Female Hypoglycemic Agents - isolation & purification Hypoglycemic Agents - therapeutic use Hypolipidemic Agents - isolation & purification Hypolipidemic Agents - therapeutic use Jaboticaba Mice Myrtaceae Plant Extracts - isolation & purification Plant Extracts - therapeutic use Random Allocation Scavenging Vitis Writhing |
title | Anti-inflammatory, hypoglycemic, hypolipidemic, and analgesic activities of Plinia cauliflora (Mart.) Kausel (Brazilian grape) epicarp |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T12%3A25%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti-inflammatory,%20hypoglycemic,%20hypolipidemic,%20and%20analgesic%20activities%20of%20Plinia%20cauliflora%20(Mart.)%20Kausel%20(Brazilian%20grape)%20epicarp&rft.jtitle=Journal%20of%20ethnopharmacology&rft.au=Brito,%20Tha%C3%ADse%20Gabriele%20da%20Silva&rft.date=2021-03-25&rft.volume=268&rft.issue=NA&rft.spage=113611&rft.pages=113611-&rft.artnum=113611&rft.issn=0378-8741&rft.eissn=1872-7573&rft_id=info:doi/10.1016/j.jep.2020.113611&rft_dat=%3Cproquest_cross%3E2635175702%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2635175702&rft_id=info:pmid/33242623&rft_els_id=S0378874120334991&rfr_iscdi=true |